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ABSTRACT: Tandem mass spectral libraries (MS/MS) are usually
built by acquiring experimentally measured mass spectra from
chemical reference compounds. We here show the versatility of in-
silico or computer generated tandem mass spectra that are directly
obtained from compound structures. We use the freely available
LipidBlast development software to generate 15 000 MS/MS spectra
of the glucuronosyldiacylglycerol (GlcADG) lipid class, recently
discovered for the first time in plants. The generation of such an in-
silico MS/MS library for positive and negative ionization mode took
5 h development time, including the validation of the obtained mass
spectra. Such libraries allow for high-throughput annotations of
previously unknown glycolipids. The publicly available LipidBlast
templates are universally applicable for the development of MS/MS libraries for novel lipid classes.
De novo structure elucidation of novel compounds requiremultiple separation and purification steps as well as the
inclusion of complex analytical methods such as liquid
chromatography coupled to high-resolution tandem mass
spectrometry (LC−MS/MS) and nuclear magnetic resonance
spectroscopy (NMR). Such an approach has been shown
recently for the discovery of glucuronosyldiacylglycerol lipids
(GlcADG) from phosphorus depleted plants.1 An alternative
strategy for compound annotation is matching experimental
MS/MS spectra to in-silico predicted MS/MS spectra as it has
been shown for complex lipids using LipidBlast,2 demonstrating
the applicability of such in-silico libraries for 50 different types
of low resolution and high resolution mass spectrometers.
While in-silico libraries like LipidBlast use heuristic modeling of
tandem mass spectra,2 prediction of mass fragmentation
patterns using first-principle methods has been described
recently by applying quantum chemical calculations for the
generation of MS1 electron ionization (EI) spectra.3 Such
principles might be transferable to collision-induced tandem
mass spectra in the future. LipidBlast encompasses over 200
000 tandem mass spectra and covers 25 lipid classes and also
provides development tools using Microsoft Excel template
files4 that can be utilized to create in-silico MS/MS libraries for
novel lipid classes and multiple adduct ions. We have previously
shown the versatility of such an approach for the identification
of mammalian stem cell lipids,5 Chlamydomonas reinhardtii and
Chlorella minutissima algal lipid research6,7 and the identi-
fication of lipids in the flagellate protists Euglena gracilis.8 Using
development templates in standard software has several
advantages. It enables (1) addition of novel lipid classes that
had not been covered in the original LipidBlast survey, (2)
addition of different acyl-chain lengths or degrees of
unsaturation that had not been covered by LipidBlast, and
(3) fast distribution of such open tandem mass spectral libraries
across laboratories. We here exemplify how a new in-silico
library can be developed including 15 000 MS/MS spectra for
positive and negative ionization mode in less than 5 h
development and validation time after experimental discovery
of a single new plant lipid.
■ METHODS
The development of new LipidBlast MS/MS spectra requires a
development sheet (Microsoft Excel) and a Visual Basic for
Applications software (Microsoft Excel VBA) that contains
programmatic code to export the MS/MS spectra. Extensive
method details can be found in the original LipidBlast
publication.2 We concisely describe the general approach
here. The creation of new in-silico MS/MS libraries requires
sample MS/MS spectra for development and a series of MS/
MS spectra for validation. Spectra were taken from original
experimental measurements and the publication itself.1 These
tandem mass spectra were used for developing the library. The
spectra were acquired on a hybrid ion trap/time-of-flight mass
spectrometer with electrospray ionization (ESI-IT-TOF-MS).
Additional supplemental raw MS/MS spectra from the same
instrument were used for validation. All spectra are freely
available for download from our Web site. Instead of a
completely independent development, we simply copied an
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existing member from the LipidBlast development sheet
(MSMS-prediction-distribute-v49.xls)4 and chose a lipid class
(sulfoquinovosyldiacylglycerol, SQDG) similar to the novel
GlcADG lipid class as a starter template. In-silico structures
were generated by replacing the SQDG core structure with
GlcADG in the SMILES (Simplified Molecular Input Line
Entry System) structure codes using text based find-and-replace
in Microsoft Excel. The resulting SMILES codes were used to
calculate a series of required molecular properties using the
ChemAxon cxcalc command line tools.9 The properties
included were accurate mass, octanol−water partition coef-
ficient (log P), and the InChIKey. The values in the copied
SQDG Microsoft Excel template sheet were subsequently
adjusted for the novel GlcADG adduct ions as well as observed
GlcADG fragmentations. The associated VBA code was
modified to allow the export of the GlcADG lipids. Tandem
mass spectrometry MSP files were converted by the LIB2NIST
program, and the resulting libraries were copied as a
subdirectory into the NIST MS Search program. The libraries
were then used to further validate MS/MS spectra using the
NIST MS Search program and for batch-wise comparison using
the NIST MSPepSearch program.2,4
■ RESULTS AND DISCUSSION
We created a total of 15 000 novel in-silico MS/MS spectra for
the glucuronosyldiacylglycerol lipid class using the LipidBlast
development templates. A total of 5000 tandem mass spectra
were modeled for positive [M + NH4]
+ ionization mode and
10 000 MS/MS spectra for negative ionization mode [M −
H]−. The negative ionization mode numbers are twice the size
because they cover spectra for low-CID (collision-induced
dissociation) and high-CID voltage mode. Lipids with acyl
carbon chain lengths C2 to C26 and degrees of unsaturation
with double bond counts of 0−6 are included. The peak
fragments and their individual abundances were modeled
according to a reference spectrum obtained from an ion trap/
time-of-flight mass spectrometer (see Figure 1). This approach
is feasible because lipids follow very consistent fragmentation
rules. For MS/MS library search we used accurate mass
precursor search with subsequent product ion matching. The
details of the matching procedure are outlined in the original
Figure 1. Single published tandem mass spectrum from a novel plant lipid class glucuronosyldiacylglycerol (GlcADG) was used for development of
5 000 related lipids. Using the LipidBlast templates in-silico MS/MS spectra with different acyl chain lengths and degrees of unsaturation were
modeled. The tandem spectrum of GlcADG(18:3/16:0) shown here is observed in negative ionization mode precursor m/z 765.51529 Da.
Figure 2. Additional published tandem mass spectra were used for validation of the novel LipidBlast library. All in-silico MS/MS spectra were
created using the freely available LipidBlast templates. In top panels (red) the experimental MS/MS spectra are given, in lower panels (depicted in
blue), predicted MS/MS spectra validated this approach. These spectra can be used for high-throughput annotations of lipids.
Figure 3. In-silico library can be used for assignment of MS/MS spectra from different platforms. Left panel, MS/MS from Finnigan-MAT TSQ70
with FAB ionization of a Mycobacterium smegmatis glycolipid14 and right panel, MS/MS from Thermo-Finnigan LTQ-FT-MS.11 The in-silico spectra
shown here are low-CID voltage spectra with abundant precursor ions. Experimental spectra are depicted on top (red) and in-silico MS/MS spectra
are shown on the bottom (blue).
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LipidBlast paper.2 Short, the precursor filter removes many
false candidates that fall outside a given mass window. The
subsequent product ion matching algorithm uses traditional
similarity scoring of remaining candidates. Reverse search
scores can be used in case of impurities or nonexplained
peaks.10
We validated the negative ionization mode in-silico MS/MS
spectra with four experimentally obtained tandem mass spectra
from the same class (see Figure 2). These experimental spectra
matched the in-silico generated spectra, with one spectrum
(GlcADG 36:4) generating multiple assignments, due to
nonresolved ion peaks and overlapping product ions. In the
case of overlapping or not completely resolved peaks by liquid
chromatography as shown for GlcADG 36:4, lower hit scores
with more ambiguous compound annotations are obtained. In
order to increase hit scores we additionally modeled spectra for
low-CID and high-CID voltage mode. In low-CID voltage the
precursor ion has a higher peak intensity because it is not
completely fragmented. In high-CID voltage mode the
precursor ion disappears due to complete fragmentation and
the fatty acyl intensities highly increase. The CID voltage
specific modeling allows for analysis of experimental spectra
from a wider range of instruments such as triple quadrupole or
Fourier transform (FT) mass spectrometers (see Figure 3). A
final validation and application step was performed on tandem
mass spectra obtained from authentic reference standards
synthesized by Cao and Williams.11 The paper also discussed
specific product ion ratios for [M − H−sn2 + H2O]− and for
[M − H−sn1 + H2O]− that can lead to the correct positional
assignment of sn1 and sn2 fatty acyls. Such total synthesis
approaches and detailed CID investigations with different
ionization voltages will be extremely valuable for assignments of
regioisomers in future versions of LipidBlast. Currently
LipidBlast libraries cannot annotate stereochemistry, regiospe-
cificity, and position of double bonds correctly. Also a number
of bacterial fatty acids such as cyclic-, prenyl-, and epoxy fatty
acids are not yet included. However, the lipid class as well as
the total carbon and degree of unsaturation of each of the fatty
acyl chains can be correctly annotated. The positive ionization
mode [M + NH4]
+ spectra were developed in a similar way and
validated with two independent MS/MS spectra. The positive
ion mode spectra are specific for hybrid ion trap/time-of-flight
mass spectrometers. No voltage optimization has been
performed due to the lack of additional reference spectra.
Our publicly available GlcADG glycolipid library has direct
translational aspects that go beyond plant lipid research.12,13
Glucuronidated glycerolipids occur across several domains of
life or phylogenetic branches. Glucoronidyl (glucuronosyl)
lipids containing tuberculostearic acid (C18-methyl) were
found and analyzed in mycobacterial lipid extracts11,14,15 from
Mycobacterium smegmatis (see left panel of Figure 3) and other
species. Recent research discussed glycolipid antigen activity
and the preferred binding of natural killer cells (Va10 NKT)
toward glucuronosyl diacylglycerol lipids.16 It has to be
mentioned that in the current GlcADG LipidBlast library the
C18-methyl group (tuberculostearic acid) is not directly
assigned but rather annotated as C19 fatty acid. Glycolipids
with similar structures were also observed in Gram-negative
bacteria, Pseudomonas diminuta,17,18 Hyphomonas jannaschi-
ana,19 Agrobacterium tumefaciens,20 and Gram-positive bacteria
such as Corynebacterium glutamicum.21 GlcADG related
glycolipids were also found in the fungus Aspergillus
f umigatus.22 Diacylglyceryl-alpha-D-glucuronide algal lipids
have been found in Pavlova lutheri algae.23,24 The GlcADG
lyso-forms (one acyl chain) as well as ether analogues
(plasmenyl, plasmanyl) have been described in the literature
for use as lipid haptens25 and synthesized for membrane
property estimations,26 but no evidence has been found that
they exist in nature yet.
Most of the publications did not report MS/MS spectra in
the past. Subsequently such spectra could not be accumulated
in large electronic mass spectral databases such as Wiley
MSforID,27 ReSpect,28 MassBank,29 NIST,30 or Metlin.31 We
close that gap with our publicly available in-silico MS/MS
library, enabling future research groups to perform high-
throughput analysis of complex glycolipid mixtures by simply
extending and using LipidBlast.
The fast development of in-silico MS/MS spectra using the
LipidBlast Excel templates shows the versatility and broad
application domains of our LipidBlast software. The developed
libraries and new templates are freely provided for commercial
and noncommercial reuse with a Creative Commons-By
Attribution (CC-BY) license and can be found under http://
fiehnlab.ucdavis.edu/projects/LipidBlast.
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